Vassilios Sikavitsas to Recombinant Fusion Proteins
This is a "connection" page, showing publications Vassilios Sikavitsas has written about Recombinant Fusion Proteins.
Connection Strength
0.033
-
Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Mol Cancer Ther. 2017 09; 16(9):1855-1865.
Score: 0.033
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.